Could a nerve channel blocker replace opioids? early study investigates
NCT ID NCT07511400
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called suzetrigine, which blocks a specific nerve channel (NaV1.8) involved in pain signaling. In 67 healthy volunteers, tiny amounts were injected into the skin alongside a placebo and lidocaine. Participants received six different types of brief pain (electrical, mechanical, chemical, heat, cold, acid) to see which ones the drug could reduce. The goal is to understand which pain types depend on NaV1.8, potentially guiding development of new, non-opioid pain treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Suzetrigine (a selective NaV1.8 blocker) and lidocaine (a standard local anesthetic)
What this could lead to
If successful, this study could help identify which types of pain are best treated by targeting NaV1.8, paving the way for new non-opioid pain medications.
What could go wrong
This is a very early, small study in healthy volunteers using tiny doses injected into the skin. Results may not apply to real-world pain or lead directly to a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Vienna
Vienna, State of Vienna, 1090, Austria